Literature DB >> 9249061

Analysis of the promoter and transcription start sites of the human thrombospondin 2 gene (THBS2).

K W Adolph1, D J Liska, P Bornstein.   

Abstract

To identify features of the human thrombospondin 2 gene (THBS2) important for regulation of expression, the sequences of 5 kb of the promoter/5' flank and 3 kb of transcribed and intronic DNA were determined. Two repetitive sequences were found: an MLT1c element located 2.2 kb 5' of exon 1 and, further 5', 1.8 kb of a Tigger1 element. Putative transcription factor binding sites that might be significant for THBS2 regulation included p53, NF-kappaB, Spl, Myc-CF1, NF-Y, CF1, AP1, and GATA sites. Alignment of the promoter/5' flank sequence with the mouse Thbs2 promoter revealed 78% identity for a 450 bp region immediately upstream from the mouse transcription start site. No significant homology was detected between the human thrombospondin 2 and thrombospondin 1 promoters. Comparison of the THBS2 genomic and cDNA sequences revealed that, in contrast to Thbs2, exon 1 is divided into exons 1A and 1B by a small (93 bp) intron. The transcription start site was investigated by a PCR procedure and by 5' RACE, and yielded a size for exon 1A of at least 186 bp. Tissue-specific differences in transcription start sites were found, with transcript lengths in the order: fetal lung > adult lung > fetal brain. These results suggest that tissue-specific differences in expression of the THBS2 gene may be determined, in part, by selection of the transcription start site and resulting differences in the 5' untranslated region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249061     DOI: 10.1016/s0378-1119(97)00070-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

Authors:  Margit A Huber; Ninel Azoitei; Bernd Baumann; Stefan Grünert; Andreas Sommer; Hubert Pehamberger; Norbert Kraut; Hartmut Beug; Thomas Wirth
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

2.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Elevated Thrombospondin 2 Contributes to Delayed Wound Healing in Diabetes.

Authors:  Britta Kunkemoeller; Tara Bancroft; Hao Xing; Aaron H Morris; Amelia K Luciano; Jason Wu; Carlos Fernandez-Hernando; Themis R Kyriakides
Journal:  Diabetes       Date:  2019-08-07       Impact factor: 9.461

Review 4.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

5.  Role of the Yes and Csk tyrosine kinases in the development of a pathological state in the human retina.

Authors:  Lyudmila Baranova; Valentina Emelyanova; Igor Volotovski
Journal:  Mol Biol Rep       Date:  2009-09-13       Impact factor: 2.316

6.  Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.

Authors:  Mark D Aupperlee; Yong Zhao; Ying Siow Tan; Jeffrey R Leipprandt; Jessica Bennett; Sandra Z Haslam; Richard C Schwartz
Journal:  Endocrinology       Date:  2014-04-02       Impact factor: 4.736

7.  Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.

Authors:  Spencer Slavin; Chiuan-Ren Yeh; Jun Da; Shengqiang Yu; Hiroshi Miyamoto; Edward M Messing; Elizabeth Guancial; Shuyuan Yeh
Journal:  Carcinogenesis       Date:  2013-12-28       Impact factor: 4.944

8.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

9.  MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

Authors:  Zhenyuan Qian; Lijie Gong; Yiping Mou; Yong Han; Shusen Zheng
Journal:  Oncol Rep       Date:  2019-09-12       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.